News & Updates

Single-tablet D/C/F/TAF measures up in HIV+ people with comorbidities

17 Aug 2020 by

The once-daily single-tablet combination therapy comprising darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) yields high virologic response rates over 96 weeks in patients with HIV-1, regardless of the presence of neurologic and/or psychiatric comorbidities (NPCs), a subgroup analysis presented at the AIDS 2020 virtual conference has shown.

Single-tablet D/C/F/TAF measures up in HIV+ people with comorbidities

17 Aug 2020

Hypertensive patients at greater risk of severe COVID-19

17 Aug 2020 by

The coronavirus disease 2019 (COVID-19) is more likely to turn into a severe disease in patients with hypertension, according to a recent Chiba study.

Hypertensive patients at greater risk of severe COVID-19

17 Aug 2020

Faecal microbiota transplantation provides long-term cure for recurrent CDI

15 Aug 2020

Most patients with recurrent Clostridioides difficile infection (rCDI) experience long-term cure after faecal microbiota transplantation (FMT), reports a study that claims to be the largest and longest investigation on the safety and efficacy of FMT for rCDI treatment.

Faecal microbiota transplantation provides long-term cure for recurrent CDI

15 Aug 2020

Point-of-care HCV screening with direct access improves linkage of care in people with substance misuse

14 Aug 2020 by

Decentralized point-of-care (PoC) education and screening among individuals with substance misuse at high risk for hepatitis C virus (HCV) improves case identification, linkage to care, and HCV care cascade, which lead to better treatment uptake, according to a Singapore study.

Point-of-care HCV screening with direct access improves linkage of care in people with substance misuse

14 Aug 2020

Hormonal contraceptive + TDF-based ART a recipe for bone disaster in young HIV+ women?

14 Aug 2020 by

The concomitant use of depot medroxyprogesterone acetate (DMPA) in young women with HIV initiating an antiretroviral therapy (ART) regimen containing tenofovir disoproxil fumarate (TDF) may lead to worsening of bone mineral density (BMD) loss, data presented at AIDS 2020 have shown.

Hormonal contraceptive + TDF-based ART a recipe for bone disaster in young HIV+ women?

14 Aug 2020

Single-tablet regimen boosts virologic response in acute/early HIV-1 infection

14 Aug 2020 by

Rapid treatment initiation with a single-tablet regimen comprising darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) demonstrated a high virological response rate in patients with acute or early HIV-1* infection, according to a subgroup analysis of the DIAMOND** study presented at AIDS 2020.

Single-tablet regimen boosts virologic response in acute/early HIV-1 infection

14 Aug 2020

Switching to B/F/TAF maintains viral suppression in HIV+ elderly

13 Aug 2020 by

Switching to a single-tablet triple-drug combination comprising bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is well tolerated while continuing to provide virologic suppression through to 48 weeks in elderly people (aged ≥65 years) living with HIV (PLWH), shows a pooled analysis presented at the AIDS 2020 virtual conference.

Switching to B/F/TAF maintains viral suppression in HIV+ elderly

13 Aug 2020

Statins may protect against C. difficile infections

13 Aug 2020 by

Use of statins appears to confer a protective benefit against the development of Clostridium difficile infection (CDI) and improve CDI treatment success, according to a study. However, its benefit on mortality remains unclear.

Statins may protect against C. difficile infections

13 Aug 2020

HIV does not worsen COVID-19 outcomes

13 Aug 2020 by

People living with HIV (PLWH) who are hospitalized for COVID-19 are not more likely to die than those without HIV despite having comorbidities associated with worse COVID-19 outcomes, a US study has shown.

HIV does not worsen COVID-19 outcomes

13 Aug 2020

Flu vaccine may reduce CV risk in high-risk individuals

12 Aug 2020 by

Individuals at high risk for influenza who receive an influenza vaccination may have a reduced risk of cardiovascular (CV) events, according to a retrospective study presented at BCVS* 2020.

Flu vaccine may reduce CV risk in high-risk individuals

12 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Single-tablet D/C/F/TAF measures up in HIV+ people with comorbidities

Single-tablet D/C/F/TAF measures up in HIV+ people with comorbidities

Hypertensive patients at greater risk of severe COVID-19

Hypertensive patients at greater risk of severe COVID-19

Faecal microbiota transplantation provides long-term cure for recurrent CDI

Faecal microbiota transplantation provides long-term cure for recurrent CDI

Point-of-care HCV screening with direct access improves linkage of care in people with substance misuse

Point-of-care HCV screening with direct access improves linkage of care in people with substance misuse

Hormonal contraceptive + TDF-based ART a recipe for bone disaster in young HIV+ women?

Hormonal contraceptive + TDF-based ART a recipe for bone disaster in young HIV+ women?

Single-tablet regimen boosts virologic response in acute/early HIV-1 infection

Single-tablet regimen boosts virologic response in acute/early HIV-1 infection

Switching to B/F/TAF maintains viral suppression in HIV+ elderly

Switching to B/F/TAF maintains viral suppression in HIV+ elderly

Statins may protect against C. difficile infections

Statins may protect against C. difficile infections

HIV does not worsen COVID-19 outcomes

HIV does not worsen COVID-19 outcomes

Flu vaccine may reduce CV risk in high-risk individuals

Flu vaccine may reduce CV risk in high-risk individuals